Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Stomach Neoplasms 1 Recurrence 1 Pseudomyxoma Peritonei 1 Neoplasms, Plasma Cell 1 Atrophy 1 Appendiceal Neoplasms 1

Interventions

Dexamethasone 18 Cyclophosphamide 16 fludarabine 11 pomalidomide 9 pembrolizumab 9 carfilzomib 9 daratumumab 7 Rituximab 7 Lenalidomide 7 Calcium Dobesilate 7 fludarabine phosphate 6 Cisplatin 6 Bortezomib 6 Gemcitabine 5 venetoclax 4 elotuzumab 4 isatuximab 3 Vincristine 3 Radiotherapy 3 Prednisone 3 Letrozole 3 Etoposide 3 Doxorubicin 3 Cytarabine 3 tisagenlecleucel 2 selinexor 2 ruxolitinib 2 palbociclib 2 ixazomib 2 dexamethasone 21-phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Recurrence × Clarithromycin × Clear all

NCT02343042 2026-05-04

STOMP

Karyopharm Therapeutics Inc

Phase 1/2 Active not recruiting

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡